# Multi-modality MRI Study on Effect to Collateral Circulation and Blood Perfusion of Acute Cerebral Infarction by Human Urinary Kallidinogenase

> **NCT02259738** · PHASE2 · COMPLETED · sponsor: **XuanwuH 2** · enrollment: 120 (actual)

## Conditions studied

- Cerebral Infarction

## Interventions

- **DRUG:** Human Urinary Kallidinogenase
- **DRUG:** Shuxuening injection

## Key facts

- **NCT ID:** NCT02259738
- **Lead sponsor:** XuanwuH 2
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2014-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02259738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02259738, "Multi-modality MRI Study on Effect to Collateral Circulation and Blood Perfusion of Acute Cerebral Infarction by Human Urinary Kallidinogenase". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02259738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*